Group-based Cardiac Rehabilitation on Patients With Coronary Artery Bypass Graft Surgery

March 18, 2024 updated by: Riphah International University

The Effect of Group-based Cardiac Rehabilitation on Pulmonary Function and Aerobic Capacity of Patients With Coronary Artery Bypass Graft Surgery

  1. To determine the effect of Moderate intensity continuous training on Pulmonary function of CABG patients.
  2. To determine the effect of MICT on aerobic Capacity of CABG patients.

Study Overview

Study Type

Interventional

Enrollment (Actual)

54

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult

Accepts Healthy Volunteers

Yes

Description

Inclusion Criteria:

  • Males and females post CABG patients with ages of 40 to 60 years postoperatively.
  • The patient with Post Op-Day 5.

Exclusion Criteria:

  • Patients who have a history of other Cardiac disorders that interfere with daily life before surgery and those having congenital cardiac anomalies, Tetralogy of Fallot.
  • Musculoskeletal and neurological disorders.
  • Age more than 60 and less than 40

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: experimental group (MICT)
MICT 3 session per week with Aerobic exercise on treadmill for 30 minute with moderate intensity.
MICT 3 session per week with Aerobic exercise on treadmill for 30 minute with moderate intensity.
Other: control group (standard protocol)
Perform standard hospital protocol 2-3 session per week
standard hospital protocol

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Borg rating of perceived exertion scale
Time Frame: 4 weeks
This scale is used to measure the appearance of the body in the reacttowith the exertion according to the vital sign and symptoms like increased heart rate, respiratory rate, sweating and muscle tiredness. This scale is ranged from 6 to 20 ranking, in thesrankingsng 6 represents "no exertion at all" and twenty reported "maximal exertion during activity". If participants reporta as 12 to 14 score othe n Borg scale this indicate that exertion is at moderate level during exertion. This scale will be used to measure the level of fatigue over all activity of life
4 weeks
6min walk test
Time Frame: 4weeks
6 min walk test is used to measure the functional status of the individuals. It will be done on both groups to measure the functional status.
4weeks

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Maria Razzaq, MS, Riphah International University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2023

Primary Completion (Actual)

January 15, 2024

Study Completion (Actual)

January 18, 2024

Study Registration Dates

First Submitted

January 18, 2024

First Submitted That Met QC Criteria

March 18, 2024

First Posted (Actual)

March 19, 2024

Study Record Updates

Last Update Posted (Actual)

March 19, 2024

Last Update Submitted That Met QC Criteria

March 18, 2024

Last Verified

March 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • REC/014131 Maria Haseen

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Post-cardiac Surgery

Clinical Trials on MICT with Aerobic exercise on treadmill

3
Subscribe